Similar articles

• Inflammation: an important mechanism for different clinical entities of coronary artery diseases.

  Li JJ. Li JJ. Chin Med J (Engl). 2005 Nov 5;118(21):1817-26. Chin Med J (Engl). 2005. PMID: 16336821 Review. No abstract available.
• [The role of inflammation in the pathogenesis of atherosclerosis].

  Banach M, Markuszewski L, Zasłonka J, Grzegorczyk J, Okoński P, Jegier B. Banach M, et al. Przegl Epidemiol. 2004;58(4):663-70. Przegl Epidemiol. 2004. PMID: 15810508 Review. Polish.
• [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].

  Trepels T, Zeiher AM, Fichtlscherer S. Trepels T, et al. Herz. 2004 Dec;29(8):769-76. doi: 10.1007/s00059-004-2637-6. Herz. 2004. PMID: 15599673 Review. German.
• [Fibrinolysis in ischemic cardiopathy: the role of plasminogen activator inhibitor 1].

  Cesari M, Sartori MT. Cesari M, et al. Cardiologia. 1999 Jan;44(1):25-32. Cardiologia. 1999. PMID: 10188326 Review. Italian. No abstract available.
• CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.

  Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly MP. Lehrke M, et al. J Am Coll Cardiol. 2007 Jan 30;49(4):442-9. doi: 10.1016/j.jacc.2006.09.034. Epub 2007 Jan 12. J Am Coll Cardiol. 2007. PMID: 17258089